ProGenaCell Restorative Therapy
Effective Regeneration and Restoration of Damaged Cells.
Fresh Human Cord Blood Cells
Build new Brain and Nerve Cells.
India • Indonesia • Mexico • United States

Welcome to ProGenaCell Biologics

ProGenaCell Biologics, a global restorative healthcare provider (California, Mexico, Indonesia and India) has developed multiple healing protocols formulated to treat a broad range of diseases and maladies.

ProgenaCell physicians are committed to effectively treating chronically ill patients – particularly neuronal conditions (e.g. Parkinson’s, autism, stoke, traumatic brain injury, etc.), autoimmune disease (e.g. M.S. chronic fatigue, lupus, etc.) and joint related pain.

ProGenaCell recently announced release of its latest state-of-the-art healing procedure; a restorative cellular therapy for treating a multitude of diseases described in the links above. These remarkable treatments can repair tissues in the body that has been damaged from age, disease or degeneration. They do this by identifying, repairing and/or restoring healthy new cells and tissues.

ProGenaCell affiliate clinics and hospitals have treated over 4,000 patients since early 2000's. ProGenaCell currently provides fresh adult and newborn mesenchymal and neuronal cellular products for the treatment of a variety of neurological, compromised immune, organ dysfunction, and cardio-vascular conditions.

ProGenaCell maintains full control over its cellular manufacturing, from blood product testing and cellular processing, to delivery of cells for clinical use. This oversight and integrative process ensures exceedingly high safety and quality levels for patients. In addition, ProGenaCell works closely with affiliate centers in modifying and advancing treatment protocols and patient care.

ProGenaCell Restorative Cellular Therapy

ProGenaCell mesenchymal and neuronal cellular products release a variety of trophic factors, growth factors, and cytokines known to enhance reparative brain process. Various treatments have been used by clinicians to limit brain cellular damage and reduce its symptoms with the help of mesenchymal and neuronal cells which are the naïve cells of our body, and capable of differentiating into various other cells of our body. Their unique differentiation, unlimited multiplication property is making them very special in the application of restorative medicines. With the help of technical advancements these cellss can be isolated from our own body or newborn cord blood to utilize in a very unique way to provoke neuronal precursor cells of the brain and spinal cord to enhance production of new neurons for replacement of damaged cells. These cells can differentiate into cells needing repair, regenerate damaged cells and help in resuming the function of the damaged organs under suitable conditions. Direct replacement of neuronal cells with functional connections is less likely given the complexity of neural networks and the short time frame in which improvement is seen. Multiple mechanisms may work in some cases contributing to overall functional improvement. In the acute to subacute phase after stroke, the intravenous route might be best as a neuroprotective or anti-inflammatory strategy. At later time intervals, intrathecal routes might be preferable to better reach ischemic areas and deliver trophic factors. In a chronic stroke, direct intracerebral injection is more preferable for delivery cells to brain areas surrounding infarction capable of enhancing recovery.

ProGenaCell Fresh vs Frozen Cellular Therapy

Freezing fresh cells creates progressive damage to each of its three development phases: 1) cooling 2) cooling, and 3) thawing. In addition to metabolic imbalances, measurable changes occur in the cell and its organelle membrane (lipid domains). These structural characteristics (transitions) result in a change in membrane fluidity from an ideal liquid-crystalline state to a far less preferred solid gel state; yielding "leaky" membranous state.

Moreover, a cascade of damaging cellular events generally occurs, including:

  • Activation/leakage of lysosomal lipoprotein.
  • Activation calcium-dependent phospholipases/release of free fatty acids.
  • Activation of cellular death.
  • Disruption of the cytoskeletal matrix.
  • Generation of free radicals/oxidative stressors caused by freezing can result in forced cellular death or gene regulated cellular death.

ProGenaCell Cellular Technology

ProGenaCell Technology

Cord Blood derived Neuronal and Mesenchymal Cellular Products

ProGenaCell physicians employ cord blood derived neuronal cells for many neurological conditions like Parkinson’s disease, Autism, cerebral palsy, spinal muscular atrophy, ataxia, optic nerve conditions, and traumatic brain injury. Mesenchymal cellular products are generally used for treating most non-neuronal derived conditions amenable to cellular therapy.

Learn More

Umbilical Cord-Derived Mesenchymal Cellular

ProGenaCell protocols utilize UCMSC for treating conditions most amenable to cellular therapy. Our injections contain a higher percentage of mesenchymal cells than UCB cellular injections...

Learn More
ProGenaCell Technology